Cargando…
Tenascin-C serum levels and its prognostic power in non-small cell lung cancer
BACKGROUND: Tenascin-C is overexpressed in the stroma of most solid malignancies and may function as a diagnostic tumor marker. This study was conducted to evaluate the potential significance of Tenascin-C as a predictive marker for tumor progression in the sera of non-small cell lung cancer (NSCLC)...
Autores principales: | Gebauer, Florian, Gelis, Suyin, Zander, Hilke, Meyer, Karl-Frederick, Wolters-Eisfeld, Gerrit, Izbicki, Jakob R., Bockhorn, Maximilian, Tachezy, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991503/ https://www.ncbi.nlm.nih.gov/pubmed/26967391 http://dx.doi.org/10.18632/oncotarget.7976 |
Ejemplares similares
-
ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer
por: Tachezy, Michael, et al.
Publicado: (2012) -
CXCR7 expression in esophageal cancer
por: Tachezy, Michael, et al.
Publicado: (2013) -
Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients
por: Zander, Hilke, et al.
Publicado: (2011) -
Expression and serum levels of the neural cell adhesion molecule L1-like protein (CHL1) in gastrointestinal stroma tumors (GIST) and its prognostic power
por: Karstens, Karl-Frederick, et al.
Publicado: (2020) -
Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)
por: Tachezy, Michael, et al.
Publicado: (2014)